shutterstock 2303779197

Sperm’s secret switch: Scientists unlock the mystery of motility

Researchers at Stockholm University have unveiled the hidden intricacies of how sperm go from passive bystanders to dynamic swimmers. This transformation is a pivotal step in the journey to fertilization, and it hinges on the activation of a unique ion transporter. Their research is published in the journal Nature [1].

shutterstock 1206995659

Researchers develop simple blood test that can help diagnose bipolar disorder

Researchers have developed a new way of improving diagnosis of bipolar disorder that uses a simple blood test to identify biomarkers associated with the condition.  

uniqsis FlowLab Column

Uniqsis introduces FlowLab Column, a 2-channel system for catalytic flow chemistry

The FlowLab Column from Uniqsis is an affordable flow chemistry system designed specifically for high temperature and pressure catalysis applications. At the heart of the FlowLab Column is a HotCoil heated reactor module fitted with a HotColumn adapter to enable operation up to +260 °C (300 °C as an option).

Kivo GO

Kivo unveils Kivo GO Document Management Solution for smaller teams

Kivo, the intuitive Document Management Solution for life sciences, has introduced Kivo GO, a unified platform for emerging life sciences teams who need to work together efficiently across all functions while maintaining compliance and security.

HORIBA POINTE G6PD

HORIBA UK expands clinical chemistry portfolio with new POINTE G6PD assay kit

HORIBA UK has expanded its clinical chemistry portfolio with the addition of a new test kit for Glucose-6-phosphate dehydrogenase (G6PD) from Pointe Scientific. HORIBA is distributing this cell function assay to the UK market following its acquisition of US-based Pointe Scientific in 2021. Used for the quantitative determination of G6PD enzyme activity in blood, the […]

Sebia MInSight

Sebia launches M-inSight, a test for monitoring multiple myeloma patients

Sebia, a world leader in multiple myeloma diagnostics and monitoring, has introduced M-inSight its serum-based Minimal Residual Disease (MRD) test for monitoring in multiple myeloma. M-inSight is a Laboratory Developed Test (LDT) being offered by Corgenix, part of the Sebia Group.

screenin3d 2

ScreenIn3D develops lab-on-chip technology for screening live tissue samples

ScreenIn3D reports on how their proprietary lab-on-a-chip technology is enabling cancer researchers to miniaturize their testing of biopsy tissue samples across a wide range of modalities and to test both single and combination drug therapies on live tissue samples.  

shutterstock 1436984567

EC approves Polpharma Biologics’ Tyruko biosimilar for MS

Polpharma Biologics, an international biotech company focused on developing and manu­facturing biosimilars, has received approval from the European Commission for Tyruko (natalizumab) as the first and only biosimilar for relapsing forms of multiple sclerosis (MS) in Europe. Tyruko was developed by Polpharma Biologics and will be commercialized by its collaboration partner Sandoz.

revvity IVIS Spectrum

Revvity unveils next-gen preclinical imaging tech

Revvity has expanded its imaging portfolio with the introduction of three new imaging systems – the IVIS platform, the Quantum GX3 microCT, and the Vega ultrasound system.

Shimadzu AIMsight

Shimadzu’s new AIMsight infrared microscope automates analysis of micro contaminants

Shimadzu has released the AIMsight infrared microscope. AIMsight builds on the high sensitivity of Shimadzu’s well-known AIM-9000 to offer an improved operational experience through greater automation. AIMsight is intended for industrial applications, such as drug manufacturing.